| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | — |
| Cost of Revenue | $1.7M | — |
| R&D Expense | $279.9M | +8.9% |
| SG&A Expense | $121.7M | +0.2% |
| Operating Income | -$389.0M | -2.8% |
| Pre-tax Income | -$231.8M | +35.0% |
| Net Income | -$231.8M | -114.4% |
| EPS (Basic) | -$4.23 | -115.9% |
| EPS (Diluted) | -$4.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.3M | -31.4% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $8.5M | — |
| Current Assets | $832.8M | -21.7% |
| Total Assets | $1.24B | -13.8% |
| Current Liabilities | $62.6M | +4.7% |
| Total Liabilities | $137.9M | -5.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$309.5M | +24.0% |
| Capital Expenditures | $4.9M | -15.0% |
| Investing Cash Flow | $243.3M | -80.5% |
| Financing Cash Flow | $2.4M | +100.3% |
| Free Cash Flow | -$314.4M | +23.9% |
| -115.9% |
| Stockholders' Equity |
| $1.10B |
| -14.8% |